Pharmacokinetics of two formulations of alendronate sodium/cholecalciferol (vitamin D₃) tablets 70 mg/5600 IU: An open-label, randomized, single-dose, two-treatment, two-period, two-sequence, cross-over, bioequivalence study

By Tippabhotla Sudhakar Koundinya   Thota Satyanarayana   Khan Sohel Md.   Gadiko Chaitanya   Yergude Sandeep   Cheerla Raju   Nakkawar Mukesh   Betha Madhava Rao   Battula Ramakrishna   Vobalaboina Venkateswarlu  

Clinical Research and Regulatory Affairs, Vol. 30, Iss. 1-2, 2013-03 ,pp. : 14-22

Informa Healthcare

Access to resources Recommend Favorite

Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young Adults: A Randomized, Open-Label, Two-Period Crossover, Single-Centre Study

By Darwish Mona   Hellriegel Edward T.   Xie Fang  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 793-801

Adis International

Access to resources Recommend Favorite

Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate: A Randomized, Open-Label, Two-Period, Crossover, Single-Dose, Single-Centre Pharmacokinetic Study in Healthy Adult Men

By Ermer James C.  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 357-370

Adis International

Access to resources Recommend Favorite

Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics: A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Subjects

By Yin Ophelia Q.P.  

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 169-179

Adis International

Access to resources Recommend Favorite